NYSE · Healthcare · Drug Manufacturers - General
AbbVie Inc.
ABBV
AbbVie Inc. CEO Robert A. Michael · Market cap $488.1B.
$276.28
+3.86 · +1.42%
52w hi $277.6052w lo $190.75
51
ROUTINE
Current InsiderScore
Corp · 90d
1
0 buys · 1 sales
Cong · 90d
1
0 buys · 1 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
7 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 14 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sell | 32,710 | $250.00 | −$8.18M | 37 |
| Mar 04 | David Ryan Purdue | SVP, Controller | Sell | 5,230 | $233.56 | −$1.22M | 37 |
| Mar 02 | Perry C Siatis | EVP, GC AND SECRETARY | Sell | 10,291 | $234.66 | −$2.41M | 37 |
| Mar 02 | Perry C Siatis | EVP, GC AND SECRETARY | Sell | 5,777 | $233.51 | −$1.35M | 30 |
| Feb 25 | Perry C Siatis | EVP, GC AND SECRETARY | Sell | 22,381 | $230.00 | −$5.15M | 37 |
| Aug 12 | Azita Saleki-Gerhardt | EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $198.42 | −$8.41M | 33 |
| Aug 05 | Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | Sell | 10,061 | $198.59 | −$2.00M | 30 |
Section 02
Recent STOCK Act disclosures
3 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Sep 21 | Pete Sessions | House · TX | Sell | $15,001 - $50,000 | $33K | 7 d | 51 |
| Jun 04 | Josh Gottheimer | House · NJ | Sell | $1,001 - $15,000 | $8K | 30 d | 51 |
| Jun 11 | Ro Khanna | House · CA | Buy | $15,001 - $50,000 | $33K | 41 d | 40 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct